These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5778233)

  • 1. Cancer chemotherapy following adrenalectomy in breast cancer patients.
    Sara Z; Hall TC; Griffiths CT
    Cancer; 1969 May; 23(5):1122-5. PubMed ID: 5778233
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of breast carcinoma.
    Shingleton WW; Sedransk N; Johnson RO
    Oncology; 1972; 26(2):287-96. PubMed ID: 5049923
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide therapy in patients with advancing breast cancer following adrenalectomy and 5-fluorouracil.
    Piro AJ; Wilson RE; Nevinny HB
    Cancer; 1971 Jun; 27(6):1342-5. PubMed ID: 5088210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role and limitations of chemotherapy in breast cancer].
    Cattan A; Pourny C
    Sem Hop; 1975 Jul 10-20; 51(31-34):2119-21. PubMed ID: 170687
    [No Abstract]   [Full Text] [Related]  

  • 6. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 7. Polychemotherapeutic treatment of patients with metastatic breast cancer.
    Balázs M; Tüske M
    Acta Med Hung; 1986; 43(4):407-11. PubMed ID: 3601586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of vincristine sulfate and cyclophosphamide chemotherapy for metastatic neuroblastoma.
    Sullivan MP; Nora AH; Kulapongs P; Lane DM; Windmiller J; Thurman WG
    Pediatrics; 1969 Nov; 44(5):685-94. PubMed ID: 5374979
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxic drug and hormone therapy after adrenalectomy for advanced breast cancer.
    Keating JL; Yonemoto RH; Byron RL
    Surg Gynecol Obstet; 1968 Sep; 127(3):538-42. PubMed ID: 4969618
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of patients with carcinoma of the breast to hormonal therapy and combination chemotherapy.
    Henderson MD; Buroker TR; Samson MK; Mood DW; Baker LH; Vaitkevicius VK
    Surg Gynecol Obstet; 1975 Aug; 141(2):232-4. PubMed ID: 1154233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA; Grillo-López A; Vélez-Garciá E
    Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormones, chemotherapy, and the breast cancer patient.
    Watne AL; Covey TH
    Oncology; 1972; 26(2):317-26. PubMed ID: 4626139
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study.
    van Oosterom AT; Powles TJ; Hamersma E; Smith IE; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():275-6. PubMed ID: 6797825
    [No Abstract]   [Full Text] [Related]  

  • 15. The phase II study: some reflections, particularly concerning disseminated breast cancer.
    Ahmann DL
    Cancer Chemother Rep 3; 1972 May; 3(1):29-32. PubMed ID: 5049705
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
    Muss HB; White DR; Cooper MR; Richards F; Spurr CL
    Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy in breast cancer: back to the future.
    Colleoni M; Goldhirsch A
    Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
    [No Abstract]   [Full Text] [Related]  

  • 19. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 20. Some aspects of chemotherapy in breast carcinomatosis.
    Arthur K
    Clin Radiol; 1968 Jul; 19(3):351-6. PubMed ID: 4175702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.